SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Coates RJ,Uhler RJ,Brogan DJ, et al. Patterns and predictors of the breast cancer detection methods in women under 45 years of age. Cancer Causes Control. 2001; 12: 431442.
  • 2
    Joensuu H,Lehtimaki T,Holli K, et al. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA. 2004; 292: 10641073.
  • 3
    Moody-Ayers SY,Wells CK,Feinstein AR. “Benign” tumors and “early detection” in mammography-screened patients of a natural cohort with breast cancer. Arch Intern Med. 2000; 160: 11091115.
  • 4
    Porter PL,El-Bastawissi AY,Mandelson MT, et al. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 1999; 91: 20202028.
  • 5
    Gilliland FD,Joste N,Stauber PM, et al. Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst. 2000; 92: 743749.
  • 6
    Shen Y,Yang Y,Inoue LYT,Munsell M,Miller AB,Berry DA. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Inst. 2005; 97: 11951203.
  • 7
    Senie RT,Lesser M,Kinne DW,Rosen PP. Method of tumor detection influences disease-free survival of women with breast carcinoma. Cancer. 1994; 73: 16661672.
  • 8
    Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet. 1998; 351: 14511467.
  • 9
    Early Breast Cancer Trialists' Collaborative Group. Multi-agent chemotherapy for early breast cancer: an overview of the randomised trials. Lancet. 1998; 352: 930942.
  • 10
    Berry DA,Cronin KA,Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005; 353: 17841792.
  • 11
    Breen N,Wagener DK,Brown ML,Davis WW,Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst. 2001; 93: 17041713.
  • 12
    Makuc DM,Breen N,Freid V. Low income, race, and the use of mammography. Health Serv Res. 1999; 34(1 pt 2): 229239.
  • 13
    Smith-Bindman R,Miglioretti DL,Lurie N, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006; 144: 541553.
  • 14
    Bradley CJ,Given CW,Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002; 94: 490496.
  • 15
    Ballard-Barbash R,Potosky AL,Harlan LC,Nayfield SG,Kessler LG. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Educ. 1996; 88: 716726.
  • 16
    Boyd C,Zhang-Salomons JY,Groome PA,Mackillop WJ. Associations between community income and cancer survival in Ontario, Canada and the United States. J Clin Oncol. 1999; 17: 22442255.
  • 17
    Eley JW,Hill HA,Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994; 272: 947954.
  • 18
    Ries LAG,Eisner MS,Kosary CL, et al. SEER Cancer Statistics Review, 1975–2002. Bethesda, Md: National Cancer Institute; 2005.
  • 19
    FlemingID,CooperJS,HensenDE, eds. AJCC Cancer Staging Manual,5th ed. Philadelphia, Pa: Lippincott-Raven; 1998.
  • 20
    Humphrey LL,Helfand M,Chan BK,Woolf SH. Breast cancer screening: a summary of evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002; 137: 347360.
  • 21
    Breen N,Yabroff KR,Meissner HI. What proportion of breast cancers are detected by mammography in the United States? Cancer Detect Prev 2007; 31: 220224.
  • 22
    Harlan LC,Clegg LX,Abrams J,Stevens JL,Ballard-Barbash R. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987–2000. J Clin Oncol. 2006; 24: 872877.
  • 23
    Charlson ME,Pompei P,Ales KL.,MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987; 40: 373383.
  • 24
    Carlson RW,Goldsetin LJ,Gradishar WK, et al. Update of the NCCN guidelines for treatment of breast cancer. Oncology. 1997; 11: 199220.
  • 25
    National Institutes of Health. Adjuvant Therapy for Breast Cancer. NIH Consensus Statement 2000 November 1–3. Bethesda, Md: National Institutes of Health; 2000.
  • 26
    SAS Institute Inc. SAS/STAT User's Guide, 4th ed, version 6. Cary, NC: SAS Institute Inc.; 1989.
  • 27
    Enger SM,Thwin SS,Buist DSM, et al. Breast cancer treatment of older women in integrated health care settings. J Clin Oncol. 2006; 24: 43774383.
  • 28
    Paik S,Shak S,Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated node-negative breast cancer. N Engl J Med. 2004; 351: 28172826.
  • 29
    Nemoto T,Natarajan N,Smart CR,Mettlin C,Murphy GP. Patterns of breast cancer detection in the United States. J Surg Oncol. 1982; 21: 183188.
  • 30
    Conway BJ,Suleiman OH,Rueter FG,Antonsen RG,Slayton RJ. National survey of mammography facilities in 1985, 1988, and 1992. Radiology. 1994; 191: 323330.
  • 31
    Hendrick RE,Chrvala C,Plott CM,Cutter GR,Jessop NW,Wilcox-Buchalla P. Improvement in mammography quality control: 1987–1995. Radiology. 1998; 207: 663668.
  • 32
    Harlan LC,Abrams J,Warren JL,Clegg L,Stevens J,Ballard-Barbash R. Adjuvant therapy for breast cancer: practice patterns of community physicians. J Clin Oncol. 2002; 20: 18091817.
  • 33
    Aiello EJ,Buist DS,Wagner EH, et al. Diffusion of aromatase inhibitors for breast cancer therapy between 1996 and 2003 in the Cancer Research Network. Breast Cancer Res Treat. 2007 [Epub ahead of print].
  • 34
    Carlson RW,Anderson BO,Bensigner W, et al. Update: NCCN practice guidelines for the treatment of breast cancer. Oncology. 1999; 13(5A): 4166.
  • 35
    Characteristics of the SEER population compared with the total United States population. 2006. Available at URL: http://seer.cancer.gov/registries/characteristics.html Accessed on December 18, 2007.